Cephalexin (Keflex) is NOT recommended for pneumonia treatment
Cephalexin is not included in any current guideline-recommended regimens for community-acquired pneumonia (CAP) in adults or children. The major society guidelines explicitly recommend other antibiotics, and cephalexin lacks adequate coverage for the most common pneumonia pathogens.
Why Cephalexin Should Not Be Used for Pneumonia
Guideline Recommendations Exclude Cephalexin
For Adults with CAP 1:
- Outpatient (non-severe): β-lactam (ampicillin-sulbactam, cefotaxime, ceftriaxone, or ceftaroline) PLUS macrolide, OR respiratory fluoroquinolone alone
- Inpatient (severe): β-lactam PLUS macrolide OR β-lactam PLUS fluoroquinolone
- Cephalexin is notably absent from all treatment algorithms
For Children with CAP 2:
- Outpatient (<5 years): Amoxicillin 90 mg/kg/day in 2 doses
- Outpatient (≥5 years): Amoxicillin 90 mg/kg/day in 2 doses (up to 4 g/day)
- Inpatient: Ampicillin, penicillin G, ceftriaxone, or cefotaxime
- Again, cephalexin is not mentioned as an appropriate option
FDA Labeling Does Not Include Pneumonia
The FDA-approved indications for cephalexin 3 include:
- Respiratory tract infections (but specifically streptococcal pharyngitis, NOT pneumonia)
- Skin and skin structure infections
- Otitis media
- Genitourinary tract infections
Pneumonia is conspicuously absent from the approved indications.
Limited and Outdated Evidence
The only research supporting cephalexin for pneumonia is a small 1983 study 4 with just 34 patients comparing cefadroxil and cephalexin for mild-moderate community-acquired pneumonia. This 40-year-old evidence:
- Predates modern understanding of pneumonia pathogens
- Involved only mild cases
- Has been superseded by extensive guideline development based on higher-quality evidence
- Does not reflect current resistance patterns
What Should Be Used Instead
For Adults (Outpatient CAP) 1:
- First-line: Amoxicillin-clavulanate OR doxycycline OR a respiratory fluoroquinolone (levofloxacin 750 mg daily or moxifloxacin 400 mg daily)
- Alternative: Amoxicillin PLUS macrolide
For Children (Outpatient CAP) 2:
- Age <5 years: Amoxicillin 90 mg/kg/day divided in 2 doses
- Age ≥5 years: Amoxicillin 90 mg/kg/day divided in 2 doses; add macrolide if atypical pathogen suspected
For Hospitalized Patients:
Both adult and pediatric guidelines recommend intravenous β-lactams (ceftriaxone, cefotaxime, ampicillin) combined with macrolides or fluoroquinolones for adequate coverage of S. pneumoniae, H. influenzae, and atypical pathogens.
Critical Pitfall to Avoid
Do not use first-generation cephalosporins (cephalexin, cefadroxil) for pneumonia. These agents have:
- Inadequate coverage for H. influenzae (a common pneumonia pathogen)
- No coverage for atypical pathogens (Mycoplasma, Chlamydophila)
- Inferior lung tissue penetration compared to recommended agents
- No support in modern evidence-based guidelines
If a cephalosporin is needed for pneumonia, use third-generation agents (ceftriaxone 1-2 g daily for adults; ceftriaxone or cefotaxime for children) as specified in guidelines 1, 2.